An international consortium investigating the genetics behind the usage of hallucinogenic drugs, similar to earlier consortia into cannabis usage. This project will cover Lifelines’ contribution to the overall meta-anaysis.
Lifelines participation in the HallucinoGenes consortium
Year of approval
2026
Institute
UMCG - Department of Epidemiology
Primary applicant
Snieder, H.